- Home
- Publications
- Publication Search
- Publication Details
Title
Macrophage activation syndrome in the era of biologic therapy
Authors
Keywords
-
Journal
Nature Reviews Rheumatology
Volume 12, Issue 5, Pages 259-268
Publisher
Springer Nature
Online
2016-03-24
DOI
10.1038/nrrheum.2015.179
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Failed CTL/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time
- (2015) Misty R. Jenkins et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis under Treatment with Tocilizumab
- (2015) S. Yokota et al. JOURNAL OF RHEUMATOLOGY
- Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ
- (2015) Karen Put et al. RHEUMATOLOGY
- Inhibition of Natural Killer Cell Cytotoxicity by Interleukin-6: Implications for the Pathogenesis of Macrophage Activation Syndrome
- (2015) Loredana Cifaldi et al. Arthritis & Rheumatology
- Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab
- (2015) Alexei A. Grom et al. Arthritis & Rheumatology
- Benefit and a possible risk of tocilizumab therapy for adult-onset Still’s disease accompanied by macrophage-activation syndrome
- (2014) Masafumi Kobayashi et al. Modern Rheumatology
- Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation
- (2014) Neil Romberg et al. NATURE GENETICS
- An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome
- (2014) Scott W Canna et al. NATURE GENETICS
- Mutations of familial hemophagocytic lymphohistiocytosis (FHL) related genes and abnormalities of cytotoxicity function tests in patients with macrophage activation syndrome (MAS) occurring in systemic juvenile idiopathic arthritis (sJIA)
- (2014) Claudia Bracaglia et al. Pediatric Rheumatology
- Genetic Defects in Cytolysis in Macrophage Activation Syndrome
- (2014) Mingce Zhang et al. Current Rheumatology Reports
- The Systemic-Onset Variant of Juvenile Idiopathic Arthritis Needs to Be Recorded as an Autoinflammatory Syndrome: Comment on the Review by Nigrovic
- (2014) Donato Rigante et al. Arthritis & Rheumatology
- A56: Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Tocilizumab
- (2014) Angelo Ravelli et al. Arthritis & Rheumatology
- Whole-Exome Sequencing Reveals Overlap Between Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis and Familial Hemophagocytic Lymphohistiocytosis
- (2014) Kenneth M. Kaufman et al. Arthritis & Rheumatology
- Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis
- (2014) Norman T. Ilowite et al. Arthritis & Rheumatology
- Interferon-γ Mediates Anemia but Is Dispensable for Fulminant Toll-like Receptor 9-Induced Macrophage Activation Syndrome and Hemophagocytosis in Mice
- (2013) Scott W. Canna et al. ARTHRITIS AND RHEUMATISM
- Hemophagocytic Lymphohistiocytosis: Advances in Pathophysiology, Diagnosis, and Treatment
- (2013) Shanmuganathan Chandrakasan et al. JOURNAL OF PEDIATRICS
- Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: The diagnostic significance of interleukin-18 and interleukin-6
- (2012) Masaki Shimizu et al. CYTOKINE
- Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Nicolino Ruperto et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Fabrizio De Benedetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protection from Inflammatory Organ Damage in a Murine Model of Hemophagocytic Lymphohistiocytosis Using Treatment with IL-18 Binding Protein
- (2012) Laura Chiossone et al. Frontiers in Immunology
- Amplification of the response to Toll-like receptor ligands by prolonged exposure to interleukin-6 in mice: Implication for the pathogenesis of macrophage activation syndrome
- (2011) Raffaele Strippoli et al. ARTHRITIS AND RHEUMATISM
- Gene expression profiling of peripheral blood mononuclear cells from children with active hemophagocytic lymphohistiocytosis
- (2011) J. Sumegi et al. BLOOD
- Perforin is a critical physiologic regulator of T-cell activation
- (2011) J. E. Lykens et al. BLOOD
- How I treat hemophagocytic lymphohistiocytosis
- (2011) M. B. Jordan et al. BLOOD
- Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH
- (2011) K. Zhang et al. BLOOD
- Serum Neopterin Levels as a Diagnostic Marker of Hemophagocytic Lymphohistiocytosis Syndrome
- (2011) Maria F. Ibarra et al. Clinical and Vaccine Immunology
- Repeated TLR9 stimulation results in macrophage activation syndrome–like disease in mice
- (2011) Edward M. Behrens et al. JOURNAL OF CLINICAL INVESTIGATION
- An International Consensus Survey of Diagnostic Criteria for Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis
- (2011) S. DAVI et al. JOURNAL OF RHEUMATOLOGY
- Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions
- (2011) Elizabeth D. Mellins et al. Nature Reviews Rheumatology
- A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
- (2010) P. Quartier et al. ANNALS OF THE RHEUMATIC DISEASES
- Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: Report of forty-six patients from an international multicenter series
- (2010) Peter A. Nigrovic et al. ARTHRITIS AND RHEUMATISM
- XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease
- (2010) R. A. Marsh et al. BLOOD
- Macrophage Activation Syndrome Treated with Anakinra
- (2010) M. DURAND et al. JOURNAL OF RHEUMATOLOGY
- Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients
- (2010) P. M. Miettunen et al. RHEUMATOLOGY
- Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis
- (2010) M. Shimizu et al. RHEUMATOLOGY
- Familial Hemophagocytic Lymphohistiocytosis Type 5 (FHL-5) Is Caused by Mutations in Munc18-2 and Impaired Binding to Syntaxin 11
- (2009) Udo zur Stadt et al. AMERICAN JOURNAL OF HUMAN GENETICS
- IL-18 Activity in Systemic Lupus Erythematosus
- (2009) Flavia Favilli et al. Annals of the New York Academy of Sciences
- Galectin-3, A fÒ-galactoside binding lectin affects cytokine secretion by human macrophages
- (2009) Rudjer Novak et al. CYTOKINE
- Neutralization of IFNγ defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice
- (2009) Jana Pachlopnik Schmid et al. EMBO Molecular Medicine
- Anakinra for Systemic Juvenile Arthritis
- (2009) Andrew Zeft et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis
- (2009) Sebastiaan J. Vastert et al. RHEUMATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started